(in millions $) | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 | 30 Oct 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | $349.11 | $350.88 | ||
Inventory | $939.36 | $1005.61 | ||
Total current assets | $1840.54 | $2024.34 | $2259.15 | $2479.3 |
Long term investments | ||||
Property, plant & equipment | $389.73 | $353.6 | ||
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $3832.25 | $3939.32 | $4132.11 | $4386.46 |
Current liabilities | ||||
Accounts payable | $91.13 | $96.08 | ||
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $3041.97 | $2798.7 | $3487.85 | $4501.04 |
Long term debt | $1463.68 | $74.53 | ||
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $5653.57 | $5481.96 | $5378.23 | $5015.4 |
Shareholders' equity | ||||
Retained earnings | -$4855.04 | -$4195.18 | ||
Other shareholder equity | -$1821.32 | -$1542.64 | -$27.41 | -$42.8 |
Total shareholder equity |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | $349.11 | $370.16 | $247.67 | $355.43 |
Inventory | $939.36 | $657.88 | $545.74 | $432.53 |
Total current assets | $2259.15 | $2180.44 | $1606.99 | $1171.96 |
Long term investments | ||||
Property, plant & equipment | $389.73 | $262.59 | $328.82 | $201.67 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $4132.11 | $3942.45 | $3309.69 | $2548.56 |
Current liabilities | ||||
Accounts payable | $91.13 | $98.46 | $114.3 | $67.98 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $3487.85 | $3252.24 | $3040.72 | $1868.19 |
Long term debt | $1463.68 | $85.56 | $66.58 | $61.84 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $5378.23 | $4075.8 | $3187.2 | $1967.85 |
Shareholders' equity | ||||
Retained earnings | -$4855.04 | -$3726.78 | -$1761.86 | -$754.41 |
Other shareholder equity | -$27.41 | -$3737.09 | -$16.78 | $16.36 |
Total shareholder equity |
(in millions $) | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 | 30 Oct 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $572.65 | $345.35 | $534.12 | $613.2 |
Cost of revenue | ||||
Gross Profit | $1.74 | -$30.84 | -$434.29 | $3.6 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $236.34 | $200.81 | $310.72 | $264.8 |
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $13.69 | $3.31 | -$14.72 | $2.6 |
Interest expense | -$76.23 | -$123.94 | -$54.75 | -$54.4 |
Net income | ||||
Net income | -$266.99 | -$274.3 | -$726.43 | -$155.4 |
Income (for common shares) |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $2378.56 | $2461.9 | $1337.18 | $610.25 |
Cost of revenue | ||||
Gross Profit | -$413.08 | $119.4 | $0.86 | $56.52 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $1089.79 | $1028.6 | $946.4 | $499.49 |
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | -$7.14 | $16.8 | $0.34 | $13.54 |
Interest expense | -$142.14 | -$104.4 | -$61.56 | -$28.35 |
Net income | ||||
Net income | -$1194.83 | -$465.8 | -$1007.45 | -$484.86 |
Income (for common shares) |
(in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$439.4 | -$189.41 | -$281.09 | -$131.04 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | $2093.3 | $1545.35 | $1063.97 | $322.58 |
Effect of exchange rate | $0.99 | -$43.91 | -$38.6 | $2.23 |
Change in cash and equivalents | -$204.95 | -$22.79 | $83.54 | -$89.62 |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$439.4 | -$715.97 | -$129.67 | -$243.71 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | $2093.3 | $2083.03 | $909.57 | $359.64 |
Effect of exchange rate | $0.99 | -$66.43 | -$27.49 | $21.34 |
Change in cash and equivalents | -$204.95 | $217.21 | $440.25 | $80.23 |
Market cap | $2.05B |
---|---|
Enterprise value | N/A |
Shares outstanding | 2.11B |
Revenue | $2.07B |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | -$1.42B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | -1.44 |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | 0.99 |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | -$0.67 |
---|---|
ROA | -34.94% |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 0.61 |
Quick ratio | N/A |